Sequencing of the Leishmania major Friedlin genome is well underway with chromosome 1 (Chr1) and Chr3 having been completely sequenced, and Chr4 virtually complete. Sequencing of several other chromosomes is in progress and the complete genome sequence may be available as soon as 2003. A large proportion ($ 70 %) of the newly identified genes remains unclassified, with many of these being potentially Leishmania-(or kinetoplastid-) specific. Most interestingly, the genes are organized into large ( 100-300 kb) polycistronic clusters of adjacent genes on the same DNA strand. Chr1 contains two such clusters organized in a ' divergent ' manner, i.e. the mRNAs for the two sets of genes are both transcribed towards the telomeres. Chr3 contains two ' convergent ' clusters, with a single ' divergent ' gene at one telomere, with the two large clusters separated by a tRNA gene. We have characterized several genes from the LD1 (Leishmania DNA 1) region of Chr35. BT1 (formerly ORFG) encodes a biopterin transporter and ORFF encodes a nuclear protein of unknown function. Immunization of mice with recombinant antigens from these genes results in significant reduction in parasite burden following Leishmania challenge. Recombinant ORFF antigen shows promise as a serodiagnostic. We have also de-
Introduction
The numerous human-infective Leishmania spp. cause a spectrum of diseases with pathologies ranging from asymptomatic to lethal, resulting in widespread human suffering and death, as well as substantial economic loss. There is a correlation between the parasite species and disease manifestation [1] , but host factors play an important role in disease pathology. Diagnosis of Leishmania infection is insensitive, non-specific and labourintensive ; current chemotherapeutic agents are unsuitable because of their high toxicity, and there are no approved vaccines. Thus a greater knowledge of Leishmania biochemistry and genetics is sorely needed. The Leishmania genome size is $ 34 Mb and the chromosomes range in size from 0.3 to 2.8 Mb [2, 3] . The Leishmania karyotype is conserved among Leishmania species (albeit with considerable size polymorphism) and the genes are syntenic [2, 4, 5] , except that the Old World species have 36 chromosomes [2] and the New World species have 35 (L. braziliensis complex) or 34 (L. mexicana complex) [4] .
Genome sequencing
In 1994, the Leishmania Genome Network (LGN) was set up under the auspices of the World Health Organization to initiate a Leishmania genome project, and L. major MHOM\IL\81\Friedlin (LmjF) was subsequently selected as the reference strain. A first-generation cosmid contig map of the entire genome was constructed [6] , and cosmidbased genomic sequencing began in 1996. The sequence of the smallest (285 kb) Leishmania chromosome (Chr1) was completed in 1998, and 79 protein-coding genes were identified [7] . Remarkably, these genes are organized into two large polycistronic units, with the first 29 genes on one DNA strand and the remaining 50 genes on the other stand, such that their mRNAs are transcribed in a ' divergent ' manner towards the telomeres. The 257-kb ' informational ' region (containing the protein-coding genes) is flanked by telomeric and sub-telomeric sequences that differ in size by $ 29 kb between Chr1 homologues [8] . The sequence of Chr3 (385 kb) has been completed recently in the U.S.A., as well as 39 cosmids representing $ 1. 
Gene organization
As was the case with Chr1, the genes on the other chromosomes are organized into large clusters 
Chr35
with many genes adjacent on the same DNA strand (see Figure 1) . Interestingly, the gene clusters can be either divergent (as on Chr1), where the mRNAs are transcribed toward the telomeres, or ' convergent ' (on Chr3 and Chr4), where they are transcribed away from the telomeres. Indeed, it appears that these two organizations may occur on adjacent portions of the same chromosomes (e.g. Chr3). This gene organization is consistent with the previously observed polycistronic transcription of protein-coding genes in Leishmania (and other kinetoplastida) and subsequent processing to form mature mRNAs [9] . Recent nuclear run-on data for LmjF Chr1 supports this interpretation, since it appears that transcription of the protein-coding strand is significantly greater than that of the non-coding strand (S. Martinez-Calvillo and P. J. Myler, unpublished work). The processing of the precursor RNA, which occurs co-transcriptionally [10] , involves co-ordinated 3h polyadenylation of the upstream mRNA and addition of a 39-nt spliced leader sequence to the 5h ends of the downstream mRNAs (trans-splicing). Polypyrimidine tracts within the intergenic regions provide the signals for this processing [11, 12] . No introns have been discovered to date within any of the Leishmania protein-coding genes, although the recent discovery of cis-splicing in other trypanosomatids [13] suggests that this may not hold true for all Leishmania genes.
To date, almost 1000 complete genes have been identified from the cosmid sequencing, although this number is rapidly increasing and will no doubt be greater at the time of publication.
The rRNA genes have been identified, but only one tRNA gene has been found. Interestingly, it is located at the junction of two convergent gene clusters on Chr3. The largest ($ 70 %) gene category is that of the unclassified genes. Some of these represent genes encoding predicted proteins with sequence homology to proteins with unknown functions in other organisms, or those that contain uninformative sequence motifs, but most encode proteins with no identifying features or sequence similarities (other than to genes in other trypanosomatids). These may represent genes that have parasite-specific functions, or which are diverged sufficiently as to have no significant sequence similarity to their functional homologues in other species.
The gene distribution seen on Chr1, Chr3, Chr4 and Chr35 indicates that Leishmania genes do not tend to cluster into prokaryote-like operons of genes with similar function. Interestingly, however, some regions appear to have a higherthan-expected concentration of large genes with no similarity to those in other organisms. The gene density (1 gene\3.7 kb) observed within the informational regions of Chr1, Chr3 and Chr4 extrapolates to a total of $ 8600 protein-coding genes in the entire Leishmania genome. Given that $ 70 % of the protein-coding genes have no currently identified function, it is reasonable to infer that completion of the Leishmania genome sequence will identify 4000-5000 genes with potentially parasite-specific functions. Statistical analyses of the nucleotide content of Chr1 reveals a striking, non-random purine bias and GC skew that is correlated with the two polycistronic units of protein-coding genes [14] . These findings suggest that novel transcription processes in Leishmania may be responsible for the nucleotide bias, which in turn affects chromosomal gene organization. They also suggest that the junction region between the two divergent polycistronic gene clusters on Chr1 may be a candidate for an origin of DNA replication.
Leishmania DNA 1 (LD1) genes
The LD1 region, which is located $ 100 kb from one telomere of Chr35, is amplified in $ 15 % of Leishmania strains examined [15] . Comparison of a 131-kb LmjF sequence with the 35-kb sequences obtained from L. donovani and L. infantum [16] [17] [18] shows considerably more sequence conservation (91-96 %) within the protein-coding open reading frames than within the non-coding regions (79-85 %). Using antibodies against recombinant protein (rORFF), we demonstrated that ORFF is localized to the parasite nucleus [19] . Purified rORFF protein was found to be a more sensitive serodiagnostic than the total soluble antigen now in common use, and appeared specific for the L. donovani complex [20] . Immunization of mice with rORFF and rORFG proteins, individually and in combination, showed that they stimulated both humoral and cellular responses, and provided a significant degree of protection against subsequent challenge with L. donovani, with up to a 60 % reduction in liver and spleen amastigote burdens [21] .
Using successive rounds of gene replacement of the three ORFG genes in L. donovani LSB-51.1 [22] , an ORFG-null mutant was obtained. The null mutants were unable to survive in standard growth medium without added biopterin, and showed essentially no uptake of radioactive biopterin. Thus ORFG encodes a biopterin transporter and has been renamed BT1 [23] . These results suggest that uptake of biopterin by BT1 is critical for cell survival at physiological concentrations of biopterin. The BT1-null mutants showed significantly slower growth as promastigotes, even in the presence of supplemental biopterin and folate, suggesting that their ability to grow in this medium is due to uptake of biopterin via passive diffusion or a secondary (and lower-affinity) transporter. Conversely, amplification and overexpression of BT1 confers a significant growth advantage in both naturally isolated and recombinant cell lines, perhaps providing the selective pressure for the frequent amplification of LD1 seen in Leishmania isolates [24, 25] . This advantage appears to extend to macrophage infectivity, since the naturally occurring isolates with amplified BT1 show significantly higher infectivity of macrophages in vitro, while the null mutant showed a significant reduction in infectivity.
Development of a regulatable promoter system in Leishmania
The transcription-initiation site of L. donovani rRNA genes was mapped 1020 bp upstream of the 18 S rRNA gene and the promoter was functionally characterized using transient-transfection studies [26] . Three domains (k76 to k57, k46 to k27 and k6 to j4 relative to the transcriptioninitiation site) were found to mediate promoter activity, suggesting that the rRNA is not dissimilar to that of other eukaryotes. Similar results were obtained with the L. major rRNA promoter, which was active in L. major, L. donovani, L. aethiopica and L. infantum, while the L. donovani promoter showed reduced activity in L. major.
In order to adapt the prokaryotic tetracycline-responsive repressor\operator system to L. donovani, promastigotes expressing the tetracycline-repressor gene in the α-tubulin locus were transfected with a construct containing a phleomycin-resistance\luciferase fusion gene driven by the rRNA promoter (PrRNA tc ) containing two copies of the tetracycline operator sequence. The construct was targeted into the rRNA non-transcribed intergenic region in the reverse orientation relative to transcription of the rRNA gene. This system showed an increase in luciferase expression by more than 200-fold in the presence of tetracycline. Comparison with similar constructs (but lacking PrRNA tc ) integrated into the α-tubulin and rRNA loci showed that luciferase expression driven by the down-regulated PrRNA tc (i.e. in the absence of tetracycline) was $ 100-fold lower than expression by pol II (tubulin locus) and $ 5000-fold lower than expression by pol I (rRNA locus). Conversely, luciferase activity driven by the up-regulated PrRNA tc (i.e. in the presence of tetracycline) was $ 2-3-fold higher than that from pol II expression at the tubulin locus.
However, in these first-generation constructs, even in the absence of tetracycline, the luciferase activity was $ 100-fold above background, so a second-generation construct was developed, in which the selectable marker (hygromycin resistance) was expressed from an endogenous promoter on the opposite strand to the reporter gene (luciferase) under control of the tetracyclineregulated promoter. When targeted into either the rRNA (Chr27) or LD1 (Chr35) loci, this construct showed regulation of luciferase expression by over three orders of magnitude. Clones with the construct in the rRNA locus showed 10-fold higher luciferase activities than those in the LD1 locus, both in the presence and absence of tetracycline. Integration into the LD1 locus showed luciferase levels close to background in the absence of tetracycline. Induction of luciferase expression was rapid, becoming elevated by up to two orders of magnitude within 5 h of tetracycline addition, with full induction by 24 h. In contrast, luciferase activity decreased 3-4-fold within 4 h of tetracycline removal, then slowly declined until it reached background levels after about 1 week. The level of luciferase activity was dependent on tetracycline concentration, with a concentration of 0.1 µg\ml being sufficient for maximal induction, while 0.001 µg\ml resulted in little or no induction. This technology is currently being transferred into LmjF, the Leishmania strain being sequenced. The ability to tightly regulate promoter activity will be extremely useful for studying gene function in Leishmania and several applications of this inducible system are in progress.
Conclusions and future directions
The pace of sequence generation in the Leishmania genome project has increased substantially over the past year and it is likely that the entire genome will be complete by 2003. Thus, the next 2 years will see a massive explosion in the number of Leishmania gene sequences available for study. Already, serious efforts are underway in several laboratories to implement the next stages of highthroughput genome-wide analyses, such as DNA microarrays [27] and proteomics [28] . When combined with new molecular tools (such as the regulatable promoter system) for analyses of Leishmania biology, these studies will probably cause a paradigm shift in our quest to understand and control this parasite.
